Navigation Links
Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Date:1/24/2008

e dermatological, plastic and cosmetic surgery markets. Plasma energy stimulates a true, natural skin regenerative process that is supported by over 30 completed and ongoing clinical trials. Founded in 2004, Rhytec works with leading dermatologists, plastic surgeons, and cosmetic physicians to develop new technologies that enhance the skin's appearance and function, improving the quality of life for patients seeking treatment. Rhytec, Inc. is privately held, based in Waltham, MA (US), and is a subsidiary of Rhytec, Ltd. in Berkshire (UK).

About Dr. Brian Biesman:

Dr. Brian Biesman received his undergraduate and medical education at the University of Michigan where he graduated with high honors. He completed his Ophthalmology residency at the Illinois Eye and Ear Infirmary before taking fellowship training in Ophthalmic Plastic and Reconstructive Surgery at Manhattan Eye, Ear and Throat Hospital in New York, NY. Upon completion of his fellowship, Dr. Biesman returned to Chicago where he served as Chief Resident.

Dr. Biesman then moved to Boston where he assumed the Directorship of the Eye Plastics and Orbit Service and the Center for Aesthetic Eyelid and Facial Surgery at the New England Medical Center, and was an Assistant Professor of Ophthalmology at Tufts University School of Medicine. Over the next four years he earned faculty appointments in the Division of Otolaryngology at the New England Medical Center and the Divisions of Dermatology and Plastic and Reconstructive Surgery at the Beth Israel-Deaconess Medical Center in Boston. He is currently in private practice in Nashville, TN while holding the academic title of Assistant Clinical Professor at Vanderbilt University Medical Center with faculty appointments in Ophthalmology, Otolaryngology, and Dermatology.

Dr. Biesman has spoken and taught at the local, national and international levels on the topic of aesthetic laser surgery. He has authored many scientific papers and has writte
'/>"/>

SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. GSK Does Not Option XL784 for Further Development
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
8. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
9. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , COVINA, Calif., Nov. 30 /PRNewswire... and commercialization agreement with Academia Sin...n proprietary methods and Intellectual Property (I... stem cells. This method and IP was pioneered by ...ers of Academia Sinica. Professor Lin is currentl...
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNew...unced the completion of a Phase I study of CPSI-23... the production of TNF-alpha and other pro-inflamm...bility dose escalation study in healthy volunteers...inical testing. ,, All 30 enrolled subjects c...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNews...RG), the global authority on medical technology ma...facial injectable market declined by almost 5% ove...ent as a result of the economic crisis. The market...4, will return to the strong pre-recession growth ...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference 61862 1Why Holidays Dont Have To Be Happy 61860 1Why Holidays Dont Have To Be Happy 61860 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 1SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 3SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 4SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 5
...ImmuneRegen and TGen Continue Testing Possible Tre...apy Adjuvant Likely Targeting Adult Stem ... Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a ...,Inc. (OTC Bulletin Board: IRBO), today announced ... Services), an affiliate of The Translational,Geno...
...BRISBANE, Australia, Aug. 24 Physicians at Southe...designed to test the,efficacy of a new strategy fo...e toughest infectious diseases in the modern world..., which works as a,regulator of the body,s immune ...ion to patients with chronic hepatitis C viral inf...
Other Medicine Technology:ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4Drug in New Hepatitis C Clinical Trial 2
(Date:11/30/2009)...re/ -- Harrington Physician Services (HPS) is plea...ysicians Martin Devine, Leah Doret, Elizabeth Full..., These four esteemed and popular Charlton-base...soon join the Harrington family in the new Harring... under construction at 10 North Main Street, at th...
(Date:11/30/2009)...registration of a visual stimulus by the unconscio...; between the time we see an apple and the time we...r eyes, but by how long? And how does this affect ...stimates say the time delay lasts only 100 millise... Tel Aviv University psychologists says that the a...
(Date:11/30/2009)...y designed program, study finds , , MOND...ve early intervention program for toddlers with au...s language and social skills, a new study shows. ,...able to learn and make remarkable progress," said ...hed online Nov. 30 in Pediatrics , and chief sci...
(Date:11/30/2009)...0 Sunlamps and tanning ...but the ultraviolet (UV) radiation from these devi...p://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...ves them a ,healthy, glow, any tan is a sign of sk...nd Drug Administration (FDA) scientist and interna...
(Date:11/30/2009)...Physicians at Beth Israel Deaconess Medical Center...onstrating the potential for automated analysis of...alyzer System® to assist in rapidly ruling ou...epartment (ED ) patients with chest pain. The abil...cCTA has potential to significantly reduce unneces...
Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3
... Texas, Nov. 6 The following was released today,b...eport from the U.S. Department of Veterans Affairs...1105-171) substantiated waste,mismanagement and in...ion to these serious disclosures constitutes viola...
... Net Sales increase 73% over Third Quarter 2007, ...Inc. (Nasdaq: ONXX ) today reported its financial...mber 30, 2008. Onyx reported net,income of $12.2 m...d in 2007. Excluding employee stock-based compensa...
...LOS, Calif., Nov. 6 Nektar,Therapeutics (Nasdaq: ...%, or,$100.0 million, of its outstanding convertib...for a total purchase price of $47.8 million. The,c...complete," said Nektar,President and CEO Howard W....
...errals should start with emergency room doctors, s...News) -- For children and teens who suffer violenc...oring on how to safely avoid conflict and diffuse ...ding gunshot, knife and fist-fight wounds -- at em...
... PfP Launches Ad Campaign Calli... , Washington, DC (PRWEB)...for Prevention said today that President-elect Oba...rdingly, the organization launched an ad campaign ...
...nce Call Scheduled for Today - Thursday, November ...tern Time, MOUNTAIN VIEW, Calif., Nov. 6 Alexza,...day financial results for,the quarter and nine mon...nded September 30, 2008, as reported in accordance...
Other Medicine News:Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 10Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Counseling Can Combat Youth Violence 2Health News:Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 3Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 4Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 5Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 6Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 7Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 8Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 9Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 10
Sealing Mat for 384-well PCR plate
MicroAmp 24-Well Full Plate Covers
Eppendorf Sealing Mat 96
AlumaSeal Aluminum sealing film for multiwell plates
Medicine Products: